Assetmark, Inc Takeda Pharmaceutical CO LTD Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Assetmark, Inc holds 80,982 shares of TAK stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,982

Previous 76,482 5.88%

Holding current value

$1.1 Million

Previous $989,000 16.28%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$13.0 - $15.08 $58,500 - $67,860	4,500 Added 5.88%	80,982 $1.15 Million
Q2 2024 Aug 13, 2024	BUY	$12.6 - $13.67 $11,214 - $12,166	890 Added 1.18%	76,482 $989,000
Q1 2024 May 06, 2024	BUY	$13.89 - $15.04 $53,670 - $58,114	3,864 Added 5.39%	75,592 $1.05 Million
Q4 2023 Feb 09, 2024	BUY	$13.36 - $15.43 $2,578 - $2,977	193 Added 0.27%	71,728 $1.02 Million
Q3 2023 Oct 27, 2023	BUY	$15.03 - $16.32 $15 - $16	1 Added 0.0%	71,535 $1.11 Million
Q2 2023 Aug 11, 2023	BUY	$15.57 - $17.11 $77,009 - $84,626	4,946 Added 7.43%	71,534 $1.12 Million
Q1 2023 May 05, 2023	BUY	$15.28 - $16.48 $789,181 - $851,159	51,648 Added 345.7%	66,588 $1.1 Million
Q4 2022 Feb 10, 2023	BUY	$12.42 - $15.62 $13,537 - $17,025	1,090 Added 7.87%	14,940 $233,000
Q3 2022 Nov 01, 2022	BUY	$12.8 - $28.65 $12,646 - $28,306	988 Added 7.68%	13,850 $180,000
Q2 2022 Aug 03, 2022	SELL	$13.12 - $15.03 $12,595 - $14,428	-960 Reduced 6.95%	12,862 $181,000
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $15,598 - $17,683	1,152 Added 9.09%	13,822 $198,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $8,784 - $10,938	667 Added 5.56%	12,670 $173,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $17.26 $195,648 - $207,171	12,003 New	12,003 $197,000
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $1.04 Million - $1.23 Million	-62,049 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.39 - $18.97 $379,825 - $468,179	24,680 Added 66.04%	62,049 $1.13 Million
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $156,191 - $175,281	9,134 Added 32.35%	37,369 $667,000
Q2 2020 Aug 11, 2020	BUY	$14.59 - $19.5 $129,019 - $172,438	8,843 Added 45.6%	28,235 $506,000
Q1 2020 May 12, 2020	SELL	$13.02 - $20.31 $924,237 - $1.44 Million	-70,986 Reduced 78.54%	19,392 $294,000
Q4 2019 Feb 11, 2020	BUY	$16.88 - $20.83 $727,595 - $897,856	43,104 Added 91.18%	90,378 $1.78 Million
Q3 2019 Nov 13, 2019	BUY	$16.15 - $17.99 $643,238 - $716,523	39,829 Added 534.98%	47,274 $813,000
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $100,723 - $124,476	6,075 Added 443.43%	7,445 $132,000
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $22,879 - $29,482	1,370 New	1,370 $28,000

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account